StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ionis Pharmaceuticals, Inc.
NasdaqGS:IONS
Sector
Location
Market Cap
USD 6.68 B
Share Price
USD 41.95
Avg Daily Volume
1,734,188
Change (1 day)
0.96%
Change (1 year)
-17.11%
Change (YTD)
19.99%
Ionis Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2024: USD 42.96 M
Ionis Pharmaceuticals, Inc. Accounts Payable is USD 42.96 M for the year ending December 31, 2024, a 65.07% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Ionis Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2023 was USD 26.03 M, a 45.23% change year over year.
-
Ionis Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2022 was USD 17.92 M, a 50.55% change year over year.
-
Ionis Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2021 was USD 11.90 M, a -30.79% change year over year.
-
Ionis Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2020 was USD 17.20 M, a 7.05% change year over year.
Competitors
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Novo Nordisk A/S
USD 66.69
NOVO-B.CO
+2.51
3.90%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
Novartis AG
USD 116.16
NOVN.SW
+1.50
1.31%
Abbott Laboratories
USD 125.73
ABT
+1.31
1.05%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Vertex Pharmaceuticals Incorporated
USD 470.13
VRTX
+11.64
2.54%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
CSL Limited
USD 174.01
CSL.AX
+1.04
0.60%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
MERCK Kommanditgesellschaft auf Aktien
USD 128.06
MRK.DE
-0.29
-0.22%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
AbbVie Inc.
USD 187.11
ABBV
+2.26
1.22%
Novo Nordisk A/S
USD 66.69
NOVO-B.CO
+2.51
3.90%
Roche Holding AG
USD 337.58
RO.SW
-0.59
-0.18%
Novartis AG
USD 116.16
NOVN.SW
+1.50
1.31%
Abbott Laboratories
USD 125.73
ABT
+1.31
1.05%
AstraZeneca PLC
USD 140.02
AZN.L
+2.01
1.46%
Merck & Co., Inc.
USD 81.61
MRK
+2.30
2.90%
Amgen Inc.
USD 305.69
AMGN
+9.82
3.32%
Pfizer Inc.
USD 25.14
PFE
+0.88
3.63%
Gilead Sciences, Inc.
USD 110.17
GILD
+1.89
1.75%
Vertex Pharmaceuticals Incorporated
USD 470.13
VRTX
+11.64
2.54%
Sanofi
USD 97.03
SAN.PA
+0.83
0.86%
Bristol-Myers Squibb Company
USD 48.02
BMY
+1.33
2.85%
CSL Limited
USD 174.01
CSL.AX
+1.04
0.60%
GSK plc
USD 18.23
GSK.L
+0.10
0.54%
Chugai Pharmaceutical Co., Ltd.
USD 48.35
4519.T
+2.12
4.59%
Regeneron Pharmaceuticals, Inc.
USD 560.93
REGN
+15.40
2.82%
MERCK Kommanditgesellschaft auf Aktien
USD 128.06
MRK.DE
-0.29
-0.22%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.02
600276.SS
-0.06
-0.80%
Takeda Pharmaceutical Company Limited
USD 29.59
4502.T
+0.58
1.99%